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Abstract 
Here we review the results of our recent studies on neurode-
generation together with data on cerebral calcium precipita-
tion in animal models and humans, A model that integrates 
the diversity of mechanisms involved in neurodegeneration 
is presented and discussed based on the functional rele-
vance of calcium precipitation, 
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Part 1. Calcium homeostasis in the CNS: a general 
overview 
1,1, Organization 
In neu rons, calcium (Ca2+) plays a central role both as a 
charge carrier, capable of regenerative electroresponse, 
and as second messenger in cytosolic and nuclear transac-
tions, As second messenger, Ca2+ transmits signals through 
its complexation by specific proteins, inducing conforma-
tional changes that result in the regulation of phenomena in-
volved in cell plasticity and survival, Neuronal activity there-
fore depends on a fine temporal and spatial tuning of Ca2+ 
movements on an electrochemical gradient, the buffering 
capacity of fixed and mobile Ca2+ binding proteins and the 
activity of membrane-intrinsic Ca2+ -transport systems, As 
the intracellular mobility of Ca2+ is the most restricted of all 
the abundant cellular ions, oscillations result in intracyto-
plasmic concentrations in microdomains that trigger and 
control reaction cascades, These cascades regulate neu-
ronal events such as neurosecretion, formation of resting 
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Resum 
En aquest article, després d'una revisió dels nostres conei-
xements bàsics sobre moviments del calci neuronal, s'ha 
presentat el treball fet pel nostre grup durant els últims anys 
sobre neurodegeneració, juntament amb les dades obtin-
gudes en models animals i humans en l'estudi de la precipi-
tació cerebral del calci, Per tal d'explicar la precipitació del 
calci s'ha presentat i discutit un model que integra els diver-
sos mecanismes implicats en neurodegeneració des del 
punt de vista de la rellevància funcional, 
and action potentials, long-term potentiation (L TP), apopto-
sis and neuronal death [94,95], or the rescue of the latter 
[25], Rapid regulation of intraneuronal Ca2+ movement is 
crucial, allowing a punctual and localized increase, followed 
bya rapid recovery of initiallevels [12], 
Consequently, dysregulation of Ca2+ homeostasis alters 
the rapid and coherent activation of neu rons, and therefore 
is ultimately responsible for many aspects of brain dysfunc-
tion and CNS diseases, For example, an increased rate of 
Ca2+-mediated apoptosis may cause neuronal death in the 
penumbra of cerebral ischemia, or may underlie the etiology 
of chronic neurodegenerative disorders such as Alzheimer's 
or Parkinson's diseases, 
1.1.1. Comparlmentalization ot neuronal calcium 
Initiation of Ca2+ neuronal signalling is controlled by two 
types of excitable media; by the cellular membrane, which 
dominates, and by specialized intracellular organelles or 
compartments, which also participate in initiating, shaping 
and integrating calcium signals. Together with the synaptic 
cleft, each compartment has its own loading capacity and 
acts as a calcium source or drain under the control of specif-
ic proteic mechanisms which quite often coexist as different 
isoforms in the same neuron. Neuronal Ca2+ movements oc-
cur in four compartments: a) the synaptic cleft, b) the cyto-
plasm and nucleoplasm, c) the endoplasmic reticulum (ER) 
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(mainly the smooth one), the nuclear envelo pe (NE), and se-
cretory vesicles (SV), and d) the mitochondria. These com-
partments are delimited by three barriers which have specif-
ic gates that accumulate Ca2+, maintain it for a long period ot 
time, and release it in response to a stimulus. The first barrier 
corresponds to the plasmatic membrane whose gates are 
specific receptor- and voltage-operated Ca2+channels 
(ROCCs and VOCCs), a Ca2+ ATPase and a Na+f Ca2+ ex-
changer. The second barrier is composed by the topologi-
cally-related ER, NE and SV membranes which have inositol 
trisphosphate (IP3) and ryanocline receptors operated chan-
nels and a Ca2+ ATPase. The mitochondrial membrane is the 
third barrier and has a Ca2+ uniporter, a Na+f Ca2+ exchang-
er and a permeability transition pore (PTP) (See Figure 1 and 
Table 1) 
The concentric double membrane ot the NE delim its nu-
clear cisterna, with the outer membrane physically and func-
tionally continuous with the ER, and the inner membrane in-
teracting with skeletal nuclear components. 80th 
membranes are traversed by nuclear pore complexes (NPC) 
ot around 125,000 kDa [11] through which ions and small 
molecules «500 Da) diffuse treely [44]. Proteins extending 
from the NPC into the NE cisterna contain Ca2+ binding sites, 
so the Ca2+ of the NE lumen and the nucleoplasm results in 
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conformational changes that control the opening or block-
ade of the pore, thereby preventing the passage of medium 
sized molecules [11,44]. Furthermore, as a dynamic 
supramolecular assembly [44] under the control ot nuclear 
localization signals [11], NPC accommodate their resting 9 
nm diameter to the transport ot large molecules (> 70 kDa), 
which can reach up to 26 nm in ATP-activated ones [24,44]. 
In each compartment, large amounts of Ca2+ binding pro-
teins (patvalbumin, calretinin, calbindin, etc.) with a 
Kd<1).lM allow lumen storage of Ca2+, leaving less than 1 % 
in its free ionic form. In most of these proteins Ca2+ binding 
results in limited conformational modifications which have no 
direct effect on any neuronal process [33]. These moclitica-
tions explain the buffering role ot these proteins. Although 
most Ca2+ movements are directed to the cytosol, once the 
stimulus-evoked Ca2+ release has been stopped, the pres-
ence ot well-coordinated high affinityfcapacity buffers and 
transport mechanisms ensures a rapid reduction of Ca2+ 
content, thereby restoring the resting potential (i.e. from mM 
to nM in less than 10 s) [8,40,57,58,91]. 
A general ovetview of the localization of these multiple 
elements is shown in Figure 1. T able 1 summarizes the 
main characteristics of each buffer and transport mecha-
nlsm. 
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Figure 1: Schematic diagram of neuronal Ca 2+ movements. Processes responsible for Ca 2+ extrusion are energy dependent. Processes for in-
creases in cytosolic and nuclear Ca2+ are energy independent (See Table 1 for legend). 
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Nomenclature and subtypes 
L-type VOCC 
N-type VOCC 
P-type VOCC (also called Pla 
type) 
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Extra-cellular calcium 
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Endogenous & exogenous modulators 
PKC phosphorilation increases their probability of 
aperture. Inhibition by Gi/o proteins. 
There are many pharmacological important blockers 
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blockage by MVIIC w-conotoxin. 
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Inhibition by Gi/o proteins. 
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trans-splicing variants. 
AMPAlKA receptors; only subtype 
wl GluR1 & w/o GluR2 is mainly 
permeable to calcium. 
Late extra-cellular 
calcium intake into 
cytosol. 
Earlyextra-cellular 
calcium intake into 
cytosol. 
Receptor operated calcium channel 
activated by Glu,Asp,NMDA and 
ibotenic acido Also permeable to other 
ions. 
Receptor operated calcium channel 
activated by Glu, AMPA and kainate. 
Also permeable to sodium. 
Coagonism by Glycine is necesary for activation. 
Zn 2+,H+ and poliamines are alosteric factors. 
Mg2+ is a reversible blocker. 
Multiple agonists and antagonist known. 
Multiple agonists and antagonist known. 
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Neurons (and immature 
astrocytes) of cortex, 
hippocampus and 
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Other structures too. 
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GABAergic neu rons 
expressing parvalbumin. 
Wide distribution 
Wide distribution 
Wide distribution 
Subcellular 
localization 
Plasmatic 
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synaptic 
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membrane 
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membrane 
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Postsynaptic 
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1. 1.2. Exlracellular calcium 
In neuronal cells, the entry ol extracellular Ca'+ depends on 
ROCCs and VOCCs. The lormer include the two ionotropic 
glutamate receptor subtypes, a -amino-3-hydroxy-5-methyl-
4-isoxazole propionic acid (AMPA) lacking the GluR2 sub-
unit , and N-methyl-D-aspartate (NMDA), each with selective 
agon ists and antagon ists [70]. VOCCs are highly selective 
for Ca2+ and non-permeable to monovalent ions, and are 
c lassilied into live subtypes (T, L, N, P and Q), lollowing their 
pharmacolog ical and electrophysiological properties [35]. 
The T subtype is unique in its capacity to open brielly alter a 
weak depolarizat ion ol a membrane [71], while the other 
types need a greater depolarization. A high density ol the L 
subtype in dendrites may resutt in large localized increases 
in Ca'+, thereby creating microdomains. ATP associated to 
P2 purinergic receptors may regulate Ca'+ entrance [48] 
and thus d irectly link neuronal electrical activity with theen-
ergetic state ol the cell. Finally, reversion ol the Ca'+J(Na+) 
antiporter takes p lace after intense depolari zation, resulting 
in the opposite movement, i.e. the entrance ol Ca'+ [34]. 
In astrooytes, cytosolic Ca2+ movements are controlled by 
similar compartmentalized intracellular mechanisrns. 
ROCCs and VOCCs are present to a lesser extent, namely 
through AMPA and P2 receptors. VOCC exp ression is highly 
heterogeneous, the T - and L-type genes being the most ex-
pressed [98]. 
1.2. Calcium homeostasis 
The synaptic glutamate release and activation ol ionotropic 
(NMDA or AMPA) or metabotropic receptor lead to increas-
es in Ca2+ current. This resulls in membrane depolarization 
and activatian ot several cytosolic and nuclear processes. 
The concentration ol synaptic g lutamate and the activated 
receptor subtype detetmine neuronal Ca2+ mobilization, re-
sulting thus in differences in neuronal responses (Figure 2). 
Activation ot ionotropic receptors allows the direct en-
trance of extrace ll ular Ca2+, whereas metabotropic recep-
tors linked to phospholipase C (PLC) through the breakdown 
ol phosphatidylinositol 4,5-bisphosphate (PIP2) into diacy l-
g licerol (DAG) and IP3 . activate the receptor- induced Ca'+ 
release in the ER, NE and SV. Therelore, the microdomains 
ol high Ca'+ content that are close to the ER sites ol Ca'+ re-
lease activate rapid mitochondrial uptake through an elec-
trogenic uniporter. This uptake leads to Ca2+ stimulation of 
pyruvate dehydrogenase, isocitrate dehydrogenase and 2-
oxoglutarate dehydrogenase, resulting in an increase in 
neuronal respiratory capacity [92] (Figure 2). 
Ca" Irom the ER. NE and SV can also be released 
through Ihe tyanodine receptor, which is sensitive lo cyclic 
adenosi ne diphosphate ribose (cADPR). This receptor has a 
certa in degree ol homology with the IP3 receptor [56] and is 
the main responsible Ior calcium-induced calc ium release 
(CICR) [42,98]. Initial Ca2+ influx through NMDA receptors, 
VOCCs or mGluR-activated IP3 receptors, activates RyRs 
and releases Ca2+ from cell stores. Therelore, this initial in-
crease in Ca2+ content results in a temporally and spatially 
disp laced higher concentration, which in turn activates an-
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other RyR. Consequently, a Ca'+ wave is rapidly generated 
and propagated through the soma, nuc leus and axon, which 
send the initial signa I away from its origino As a micromolar 
concentration ol cytoplasmic Ca2+ is needed to trigger this 
s ignal, CICR initiation oecurs only alter a burst ol action po-
tentials, except in some particu lar situations. However, not 
on ly the amount ol Ca2+, but also ils increase is c ruc ial Ior 
CICR, especially near the release sites. IP3 receptors prevail 
in astroglial cells where they may be critical Ior the induction 
of Ca2+ waves through gap junctions. Furthermore, the pres-
ence ol lunctional ryanodine receptors is controversial [98]. 
The autonomous regu lat ion of nuclear Ca2+ has been 
suggested [1 3]. Nuclear-specilic Ca'+ signa ls must be initi-
ated by Ca2+ release channels in the inner membra ne ol the 
NE [11]. In the cytosol, the generation ol IP3 is the local point 
Ior intracellular Ca2+ signalling. Two interconnected pools ol 
PIP, have been identilied in the nuc leus, one is probably 
present in the NE and the other is located within the nucleus, 
either as part ol a proteoli pid complex, or ol the recently 
identilied invaginations ol the NE, which invade the inner 
matrix ol the nucleus [54]. With their dynamically c hanging 
morphology, these NE tubules or invaginat ions could pro-
v ide a source ol Ca2+ signals deep inside the nuc leus [11]. 
Other components required for the nuc lear inositide cycle 
are present in the nuc leus, inc luding phospholi pase C~1, 
which hydrolyzes PIP2 to generate nuc lear IP3 and diacyl-
glycerol [54]. 
The entrance ol nuclear Ca2+ can also be mediated by in-
ositol 1,3,4,5-tetrakisphosphate (IP,) or by ATP. IP, -mediat-
ed Ca2+ uptake occurs above a concentration ol 1 J..lM free 
Ca2+ but its energetic cost remains unknown. In the cytosol, 
the role ol IP, is also poorly understood. Nuc lear IP,R is a 74 
kDa protein that diUers l rom other IP, R so lar reported [54]. 
VOCC 
opening 
glutamate receptor 
activation 
release of Ca 2+ 
from internal stores 
./ 
~--- HCa2+)¡ ----
r / \ ~ 
mitochondrial fosfolipase A
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calmodulin calpains 
activation ~ I \ 
j arachidonic NiOS P1KC acid t 
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redistribution 
and modification 
~ 
LTP +ATP phosphorylation 
Figure 2: Post-synaptic mechanisms act ivated at the glutamatergic 
synap se. The glutamate-mediated increase in intrace llular Ca 2+ can 
mostly aetivate five pathways. NOS, nitrie oxide syntase; PKC, pro-
tein kinase C. 
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NPC or Ca2+ -ATPase on the inner nuclear membrane may 
mediate the extrusion ol Ca'+ lrom the nueleoplasm [54]. Fi-
nally, to control c isterna I Ca2+ stores in the nucleus, a Ca2+-
ATPase traverses a sing le bilayer, which is identical to the 
Ca'+ pump in the ER [44]. 
At rest, the extracellular med ium and the inside ol NE-ER 
network are characteri zed by > 100 f.lM Ca" I n contrast, the 
cytosol and the nucleoplasm have a lower concentration, 
around 100 nM. Locally, alter stimulation, the Ca' + content 
c lose to elusters ol IP3 or cADPR receptors may ri se tran-
siently to a lew f.lM. Ca' + signals generated in the nueleo-
plasm close to the Ca2+ release channels in the inner nuclea r 
membrane may be quickly dissipated because ol diffusion 
ol this ion through the penmeable NPCs and subsequent di-
lution into the cytoplasm, as well as its entrance into the ER. 
Any increase in cytosolic Ca2+ then activates a pump in the 
plasma membrane [73] which ext rude Ca'+ into the extracel-
lular med ium. Similarly, depletion ol Ca'+ in the NE-ER store 
opens store-operated Ca2+ channels in the plasma mem-
brane, allowing its entry. Because ol the rapid local uptake 
ol Ca'+ into the ER, this process does not necessarily alter 
cytosolic concentrations ol this ion [73]. 
When the system is overloaded (as in sustained CICR or 
tetanizing activation), Ca2+-binding proteins are saturated 
and extrusion is activated. Ca2+fNa+ antiporters, and mito-
chondrial Ca2+ uniporter reduce intracytosolic Ca2+. When 
the first wave is stopped , Ca2+ binding proteins release 
Ca'+, which is extruded by the high efficiency cytoplasmatic 
plasma membrane calc ium A TPases (PMCAs). A similar 
process takes place in mitochondria, the NE-ER network, 
and SV. 
The cytosolic membrane has two complementary sys-
tems that extrude Ca'+ to the extracellular space, PMCAs 
and Ca'+/Na+ anti porters. PMCAs are responsible Ior main-
taining the resting ionic grad ient; they have a high affinity 
and a low capacity Ior Ca' +, and are alosterically activated 
by calmodu lin (their KM decreases lrom 10 to 0. 3 f.lM). In 
contrast, Ca'+/Na+ anti porters have a low affinity but a high 
capacity and are alosterically activated by ATP (their KM de-
creases lrom 12 f.lM to 2 f.lM). This electrogenic anti porter (3 
Na+ for 1 Ca2+), which is also present in mitochondria, is dri-
ven by a gradient sustained by the Na+/K+ ATPase. In depo-
larization this system can be inverted [34]. 
Ca'+ internalization at the ER-NE is due to a lamily ol high 
perfonmance Ca'+ATPases or SERCA -sarco (endo) plas-
matic reticulum calc ium ATPases- which are present as 
three proteins; SERCA2a, SERCA2b and SERCA3. All three 
are activated at high cytoplasmic Ca2+ concentrat ions and 
are inhibited at high Iree Ca'+ content in the ER. To avoid this 
inhibition, Ca'+ binding to specrri c ER Ca'+ binding proteins, 
such as calsequestrin, can maintain a low reticular concen-
tration . 
Thus, Ca2+ movements have a critica I dependence on en-
ergy. Mitochondrial intake ol Ca2+ decreases its electro-
chemical gradient; the opening ol PTP also dissipates a con-
siderable percentile ol rnembrane potential allowing Iree 
circulation ot many ions through pores, and all extrusion sys-
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terns need ATP directly or indirectly. To restore the loss ol 
electrochemical gradient and global ATP consurnption, a 
line controlled temporal stimulation ol the mitochondrial res-
piratory chain is required. Any alteration ot the energy me-
tabolism allects Ca'+ homeostasis and vice-versa [5,8,59]. 
1.3. Calcium and gene expression 
The primary genomic response to a variety ot external sig-
nais is the rapid induction ot a set ot genes named immedi-
ate-early response genes (IEGs). Studies have implicated 
these genes in processes such as oncogenic transforma-
tion, cellular growth and differentiation, and synaptic plastic-
ity [76]. On", a lew IEGs are known to be induced by Ca'+ 
and evidence suggests that it inhibits the expression of 
some IEGs [76]. 
In PC12 cells, severallEGsare Ca'+- inducible. The most 
notable inelude the e-fos and e-jun proto-oncogenes and 
junB. Because ol its very rapid and pronounced induction by 
a variety ol agents in different cell types, the e-fos gene has 
served as a paradigm ot early response gene regulation 
[76]. Increasing intracellular Ca'+ produces the transcrip-
tional induction ot the e-fos gene. This gene contains two 
Ca2+ response elements in its promoter, the cAMP response 
element (CRE) and the serum response element (SR E). Cy-
toplasmic Ca2+ targets the SRE whi le nuclear Ca' + controls 
gene expression through the CRE [30] . 
Ca' +-activated transcription mediated by CRE and CR E-
binding protein (CREB) requires an increase in nuclear Ca' + 
content. This observation indicates that the machinery re-
sponsible Ior this response is in the nucleus. The ability ol 
CREB to activate transcription requires its phosphorylation 
on Ser 133, a reaction catalyzed by various protein kinases. 
Calmodulin kinase IV, localized in the nuc leus, is involved in 
nuclear Ca2+ -activated transcription and can activate CREB-
mediated transcription [30]. The lirst step is Ca'+-induced 
phosphorylation ol CREB on Ser 133, which leads to recruit-
ment ol the transcriptional co-activator CREB binding pro-
tein (CBP) to the promoter. The second regulatory event, 
which is crucial for transcriptional response, stimulates CBP 
activity (or a CBP associated lactor). Both events can be 
mediated by CaM kinase IV. An additional degree ol com-
plexity ol Ca' + signalling on IEG expression has been ad-
duced recently in hippocampal neurons where severa I types 
ol Ca'+ channels are linked to distinct signalling pathways. 
Activation ol CaM kinase in e-fos induction appears to be 
critical only Ior the Ca'+ that enters via the L-type channel. In 
contrast, NMDA receptor-operated Ca2+ channels use, in 
addition, a distinct pathway to induce e-fos, which may in-
volve tyrosine phosphorylation signalling and the MAP ki-
nase cascade [76]. Another lamily ol the so-called basic-he-
lix-Ioop-helix (bHLH) transcription lactors has been 
implicated in gene regulation by Ca'+ [76]. Calmodulin, cal-
c ineurin, and certain 8-100 proteins play a key role in this 
process [54]. 
Recently, it has been descri bed Ior the lirst time that a nu-
clear Ca' + sensor, DREAM (Down-stream Regu lator Element 
Antagonist Modulator), directly represses transcription by 
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binding specifically to ONA. OREAM's affinity for ONA is re-
duced upon binding to Ca2+. This represents a direct mech-
anism for Ca2+-induced gene expression that is not depen-
dent on changes in the activity ot other transcriptional 
effectors through phosphotylation or protein-protein interac-
tions. T arget genes for DREAM repression include prodynor-
phin and e-fos, indicating that OREAM may have a role in the 
regulation of a broad range of genes [15]. 
1.4. Protease activation, LTP and neuronal plasticity 
LTP is characterized by a persistent increase in synaptic ef-
ficacy resulting trom repetitive, high frequency stimulation ot 
afferent fibers. This phenomenon was first demonstrated in 
hippocampus and has since been shown to occur in most 
limbic structures and cortex. An increasing number of ex-
perimental results support the hypothesis that the substrates 
underlying LTP are related to learning and memoty process-
es [66]. Induction of LTP in the CAl hippocampal region in-
volves: (1) activation of post-synaptic NMOA receptors and 
(2) an increase in intracellular Ca2+ concentration (Figure 2). 
This increase presumably results in the activation of Ca2+-
dependent enzymes of post-synaptic cells that ultimately 
procuce stable potentiation [21]. Calpains are required for 
LTP induction, but they are not required to be constitutively 
active for LTP maintenance [22]. 
Whereas LTP induction requi res activation of NMDA re-
ceptors, LTP expression and maintenance are presumed to 
be due, in part, to modifications of AMPA receptors. It has 
been proposed that Ca2+ influx through the NMOA receptor 
channel activates calpain, which cleaves cytoskeletal pro-
teins (including spectrin), thereby resulting in the redistribu-
tion and modification of AMPA receptors in the post-synaptic 
membrane. In addition, stimulation of the NMDA receptor 
produces an accumulation of a specific spectrin breakdown 
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product (SBOP) which is generated by calpain cleavage of 
spectrin. Other processes, such as phosphorylation reac-
tions mediated by a variety of protein kinases, have also 
been proposed to participate in synaptic plasticity [28]. It 
has been suggested that cleavage of the C-terminal domain 
of GluRl by calpain results in increased AMPA receptor 
function and this mechanism also participates in LTP ex-
pression [61] (Figure 3). 
Many of the signals involved in developmental and 
synaptic plasticity in the netvous system are also involved in 
neuronal death in both physiological and pathological set-
tings. T wo prominent examples are the signal transduction 
pathways activated by neurotrophins and the excitatoty neu-
rotransmitter glutamate. Glutamate-mediated Ca2+ increase 
may activate the calpain and caspase families, which play 
key roles in modulating synaptic plasticity and in apoptotic 
neuronal death [16]. 
1.4.1. Calpains 
Calpains are Ca2+-activated cysteinyl/thiol proteases with 
two ubiquitous isozymes expressed as proenzyme het-
erodimers, calpain I with a high affinity for Ca2+, and calpain 
II with a low affinity. Within the brain, the former is mainly 
neuronal and is often active constitutively, with higher levels 
in dendrites and soma, whereas calpain II predominates in 
axons and glia and is generally activated in response to cel-
lular signals [16]. 
The activation of calpains is stimulated by an increase in 
intracellular free Ca2+, and is inhibited by the protein calpas-
tatin and bya decrease in intracellular Ca2+. Calpain I may 
be activated in the cytosol or when bound to the plasma 
membrane, whereas the activation of calpain II occurs main-
Iy at this membrane. Upon binding to Ca2+, calpains under-
go a conformational change and translocate to phospholipid 
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Figure 3: Methodological approach used to study our models of neurodegeneration. Stereotaxic acute microinjections of several compounds 
were periormed in several areas of rat brain, and the post-Iesion time varied between 13 days and one year. HPLC, high periormance liquid 
chromatography; DDRT-PCR, differential display reverse transcriptase-polymerase chain reaction. 
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membranes where limited autolysis ol the N-terminus ol both 
subunits occurs. Caspase also degrades calpastatin and 
consequently leads to increased calpain proteolytic activity. 
This model ol calpain activation proposes that al1achment 
to plasma membrane sites increases Ca2+ sensitivity, faci li-
tating autocatalytic conversion ol calpain at physiological 
concentrat ions ol this ion (100-1000 nM). The autolytica lly 
activated protease requ ires a lower concentrat ion of Ca2+ for 
its activation [1 6]. 
1.4.2. Caspases 
Lack ol trophic support and activation ol glutamate recep-
tors can induce proteolytic caspase activation in neu rons. 
Pro-caspases are constitut ive neuronal enzymes whose ac-
tiv ity is regulated through many mechanisms. The catalyt i-
cally active caspase is a tetrameric complex lormed by mul-
timerization ot pro-caspase molecules during processing 
and activation. The caspase lamily can be grouped into two 
classes: init iators and effectors. A rapid and ellective pro-
cessing ol substrate is ensured by the redundancies which 
are common among caspases, many having the ability to 
c leave the same substrates. Caspase activat ion may be de-
termined by their subcellular localization (membrane-
bound, endoplasmic reticulum, mitochondrial intermem-
brane space and extraeellular surtace ol the plasma 
membrane) [1 6]. Physical interaction with cellular proteins 
(Iike the inhibitor ol apoptosis proteins (IAPs) and Bcl-2, the 
most-studied negative regulator ol neuronal apoptosis) is 
another way to regulate caspase activation and activity. 
Overexpression ol BcI-2 protects against a range ol apopto-
sis-inducing stimuli, including trophic lactor withdrawal, glu-
tamate, oxidative insults, glucocorticoids, and DNA-damag-
ing agents [1 6]. Post-translational modilication and 
phosphorylation also regulate caspase activation. In addi-
tion, nitric oxide (NO) and reactive oxygen species can 
modu late this activ ity [84] and inhibit apoptosis. The potent 
anti-apoptotic activity ol NO is al1ributed to its ability to re-
versibly inhibit the enzymatic activity ol caspases by direct 
S-nitrosilation ot the catalytic cysteine residue that is essen-
tial Ior enzyme activ ity [80]. As caspase activat ion does not 
necessarily lead to apoptosis, it is important to bear in mind 
the physiological roles Ior caspases in synaptic plastic ity. 
Thus, because apoptosis is an irreversible phenomenon, 
caspase disactivation lollowing non-apoptotic stimuli is en-
sured by several endogenous caspase inhibitors, some ol 
which are also encoded by oncogenes and viruses [1 6]. 
Part 2. Neurodegeneration as a result of 
disturbances in calcium homeostasis 
Intracellular Ca' + overload may injure the CNS. Several stud-
ies in viva and in vitro show an association between Ca2+ in-
flux into neu rons and neurodegeneration. For example, an 
increase in intracellular Ca2+ concentration ([Ca2+]¡) partic i-
pates d irectly in the neuronal damage observed during 
cerebral ischemia and epileptic seizu res [64,96]. However, 
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the mechanisms by which Ca2+ exerts its neurotoxic actions 
remain unclear. It has been proposed that [Ca2+]1 increase 
may over-stimulate cellular processes that norrnally operate 
at low levels, or may trigger certa in cascades which are not 
usually operative [96]. Some ol the mechanisms directly 
activated by Ca'+ or Ca'+-calmoduli n include energy deple-
tion due to a loss ol mitochondrial membrane potential, pro-
duction ol reactive oxygen species (ROS), lormation ol 
membrane gap by over-activation ol phospholi pase A2, cal-
pain-induced cytoskeleton breakdown, and endonuclease-
mediated ONA degradation [59,69]. 
2.1. Calcium-mediated excitotoxicity 
A link between [Ca2+]1 increase, over-activation ol excitatory 
amino acid (EAA) receptors, and neuronal death has been 
established lrom data obtained in models ol neuronal cul-
tures, hypoxia-ischemia and after specitic stereotaxic cere-
bral lesions [1 8,26,96]. In these experimental models, the 
induced neurodegeneration can be blocked using intracel-
lular Ca' + chelators [97] or VOCC antagonists [49], remov-
ing extracellular Ca'+ [27], or emptying ce ll ular Ca'+ stores 
[45] . Thus, neurodegeneration can start after an acute injury, 
such as a hypoxic-ischemic episode or a traumatic lesion, 
whose immediate effects depend on a diversity of Ca2+ acti-
vated lesioning and compensatory mechanisms. II suffi-
c ient, the initial insult results in a chronic on-going process, 
with a prog ressive loss ol neurons. In the early 1970s, Olney 
delined excitotoxieity as the neuropathological process 
triggered alter over-stimulation ol EAA receptors [67]. At 
present, excitotoxic ity includes the concep! ot glutamate-
mediated endogenous neurotoxic ity; Le. the putative excito-
toxic ity when glutamate increases in the extracellular space 
[65]. This concept is ol interest because it presents the pos-
sibility ot new strategies in pharmacological neuroprotec-
tion. 
Thus, it is possible to develop animal models ol neu rode-
generation which are based on controlled glutamate recep-
tor over-stimulation in a selected area of the CNS while 
keeping the animal alive for some time. We used stereotaxic 
microinjections ol EAA receptor analogs, such as NMOA, 
AMPA, ibotenic and quisqualic acids, to induce an excito-
toxic lesion in brain areas ot rat thai are related to neurologi-
cal diseases in humans (Figure 3). 
2.2. Chronic excitotoxic lesion 
Because ol the complexity and diversity ol the processes 
taking place at glutamatergic synapse, any anomaly at the 
pre-synaptic, post-synaptic, or astrogliallevel may trigger a 
chronic excitotoxic processo For example, a loss ot selectivi-
ty ol ionotropic receptors [65], or deliciencies in g lial re-up-
take ol glutamate [46] are observed in lateral amiotrophic 
sclerosis. These dyslunctions contribute to explain phenom-
ena sueh as the aging-associated hypoactiv ity ol NMOA re-
ceptors observed in Alzheimer's disease [68] and the 
AMPA-reeeptor increment detected in the hippocampus ol 
aged-impaired rats [43]. We are currently using a diversity ol 
in vitro and in vivo techniques to further explain these molec-
50 Manuel J. Rodríguez, Rosa Adroor, Lluïsa de Yebra, David Ram:Jnet and Nicde Mahy 
ular and cellular mechanisms involved in neurodegeneration 
(Figure 3) 
[Ca2+]¡ increment oecurs [18], which activates the mecha-
nisms triggering neuronal death (Figure 4). Ca2+ extrusion 
and buffering are activated when the [Ca2+]¡ increases 
[96,99], with a great expenditure ot energy through Ca2+-AT-
Pases. The replacement of damaged molecules also de-
pends on ATP availability. Moreover, the high mitochondrial 
intake of Ca2+ can lead to a loss of the mitochondrial mem-
brane potential and the production ot ROS, thereby de-
creasing cellular respiratoty capacity [89]. As a result, aero-
bic glycolysis accelerates du ring the per iod soon after acute 
excitotoxicity; however, because of the mitochondrial injuty, 
If the compensatory mechanisms are not effective 
enough, the initial neuronal acute injuty due to [Ca2+]¡ in-
crease results, with time, in a chronic lesion. Cerebral le-
sions can be characterized by the area ot lesion, neuronal 
death , and the ast ro- and microglial reactions. The excito-
toxic injuty in neu rons appears after the massive entrance of 
Ca2+ and Na+ through ionotropic glutamate receptors [18], 
this entrance is supplemented by the Ca2+ release trom the 
ER after activation ot mGluRs. As a result, an excessive 
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Figure 4: Cellular alterations induced by an excitotoxic lesion. The uncontrolled increase of [Ca2+J¡ leads to apoptotic or necrotic neuronal 
death. Positive feedback of the lesion releases glutamate during this process (Adapted from Tymianski et al. 1996). 
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pyruvate is translormed into lactate with !he mly gain ol 2 
ATPs per molecule ol glucose 
Therelore limited ATP lorces a reductim in astroglial en-
er ge tic cmsumptim to lacilitate neurmal glucose availabili-
ty [51] and helpsmaintain neurmal membrane polarity as a 
priaity, In this situatim, our results have shown that intracel-
Iu lar Ca2+ may precipitate as hydroxiapatite to re duc e its cy-
toplasmic toxicity as well as the extrusion energy expenses 
in neurms and astrocytes, 
2.3. Brain calcification 
2. 3. 1. Experimenta I rrodel of bra in ca Icificafion 
Our data show that glutamate analog microinjectim in rat 
CNS leads to intracellular Ca2+ precipitatim as part ol the 
m-going induced degenerative process [52,72,87], which 
is similar to brain calcilication in humans [53] We have 
shown that Ca2+ deposits are als o induced by blockade ol 
glutamate re-uptake [46] As these deposits are observed in 
several areas ol rat brain alter microinjection ol dillerent ex-
citotoxins [7,72,78,87], their lormatim does not depend on 
the glutamate recepta subtype initially stimulated Howev-
er, their size, number and distributim vary with both the acti-
vated recepta and the CNS area (Figure 5), Fa example, 
sensitivity to AMPA-induced calcilication decreased Irom 
the globus pallidus, cerebral catex, hippocampus, medial 
septum, to retina [72,78] Moreover, in medial septum, the 
degeneratim associated with microinjection ol ibotenic and 
quisqualic acid was characterized by signilicant atrophy 
and no calcilication [52,87] However, in similar cmditims, 
AMPA microinjection resulted in similar atrophy and Ca2+ 
deposits at the injection site, 
Ca2+ deposits do not occur in all cells that degenerate in 
respmse to excitotoxins Fa example, in the basal lorebrain 
and medial septum, the calcificatim observed in GABAergic 
cells was not detected in cholinergic neurons The lormer, 
together with astrocytes, seem to participate actively in the 
calcilication process [52,53] Dillerences in the neurmal 
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phenotype ol either Ca2+ buflering and extrusim systems, 
specific energetic needs, a expressim ol the glutamate 
subtype recepta (with a key role ol mGluRI) should explain 
this variability, 
The ultrastructural study ol the tissue allected by excito-
toxicity has also cmtributed to oor understanding ol calcili-
catim In basal lorebrain and hippocampus we have char-
acterized calcified deposits within hypertrophied astrocytes 
(Figure 6), They ranged Irom 0,5 to lO).Il1l in diameter and 
were lamed by numeroos, sm all, needle-shaped crystals 
associated wi!h cellular organelles, such as microtubules, 
cisternae, vesicles a mitochmdrias, with no signs ol neu-
redegeneratim Larger inclusims were surrounded by reac-
tive microglia, a linding !hatwas als o observed in tissue alter 
specilic localizatim by in vitro autaadiography (Figure 7) 
[7,72,87] X-ray microanalysis showed an electron-dillrac-
tim ring pallern which was characteristic ol a crystalline 
structure similar to apatites [38], and a CajP ratio ol 1,3±0,2 
ol cytoplasmic deposits, a ratio lower !han !he theoretical 
apatite value ol 1 ,67 (Figure 6) This ratio is als o typical ol bi-
ological crystals which do not have an ideal aganizatim 
[78] As biolcgical hydroxyapatites, these deposits are simi-
lar to those observed in several peripheral human tissues 
[32,39] 
Experimental medels ol bme lamatim (i,e hydroxiap-
atite lamatim in vitro) [1] have shown that, instead ol Ca2+, 
a minimal amount ol phosphorus, as inorganic phosphate, is 
crucial Ior crystal nucleatim in a collagen matrix, Similarly, 
organic phosphate residues ol the phosphoproteins also 
play a direct and signilicant role in !he process ol in vitro nu-
cleation ol apatite by bme collagen, whereas collagen itsell 
does not promote the precipitatim ol Ca2+ and phosphate 
[1] Therelore in our experimental medel calcificatim de-
pends on the increase in intracellular inaganic phosphate 
(i,e ATP depletim) and, most impatantly, m the degree ol 
protein phosphaylatim Thus, the Ca2+-binding-protein-de-
pendent kinases and the activity ol neurotrophic lacta ulti-
mately cmtrol calcilication, 
-
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Figure 5 Differences in calcificatim be-
tween rat hippocampus and globus pal-
lidus alter AMPA a NMDA micwinjectims 
(a) AMPA induces small Ca2 + deposits in 
hippocampus. affecting mainly the CA1 ra-
diatum and lacunosum md eculare layers 
and 1tie mdecular layer ol dentate gyrus 
(b) AMPA micranjectim in globus pallidus 
induces large c;i2+ deposits throoghoot dif-
lerent cerebral areas, (c) NMDA infusim in 
hippocampus induces the famabm ol 
large Ca2+ deposits. which are mainly 10-
cated in 1tie pyramidallayer ol CA1 and 1tie 
granular layer ol dentate gyrus, (d) Ccm-
pari son ol the globus palli dus and hip-
pocampus AMPA dose-respmse study 
showed 1IN0 vulnerabilities to calcificatim 
Bars. 300 mm ( 
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In aqueous solutims, hydroxyapatite crystallizatim lakes 
place in lwo sequential steps [79] in the lirst, crystal nucle-
ation occurs spmtaneoosly with subsequent growth until 
scrne nancrneters, when phosphate and calcium ims reach 
a certain cmcentratim, in the second step, an accretim 
process ol !hese nanocrystals m a proteinic net takes place 
to reach a maximal size ol 2'0 micrometers, \Nhile the lirst 
process allows the re-solubilization ol the crystal, the sec-
ond prcduces astable precipitate and needs a catalysis 
agent. These lwo mechanisms may help explain the size dil-
lerences we loond belween several areas ol the CNS, Fa 
example the large insoluble Ca2+ precipitates (mean size 2'0 
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Figure 6 Characterizatim ol Ca2*de-
pOSlts (a) Intracellular Ca2+ deposit 
viewed by TEM; note its acicular structure 
corrposed by several nanocrystals (b) X-
ray microanalysis ol a nm-osmficated 
sarrple wi1ti a calculated CalP ratio ol 1.3 
(c) TEM image ol a non-osmificated de-
posit mowing needle-maped crystals (d) 
Electrm-diffraction image with a loor-ring 
pallern (arrowheads) similar to 1tiat ol hy-
droxiapatite Bars a, 0.5 ¡rn; b, 5 J-Illl; c, 
02J-1lll 
Figure 7 Increase in in vitro binding sites 
ol ft1]lazabemide and ft1]PK11195 as 
astro- and microglial markers on camal 
sectims ol rat brain alter AMPA microin-
jectim (a) fH]lazabemide binding mO\l\'-
ing basal astro;Jliallevels in a contrd rat 
(b)AMPA micranjecbm in glcbus pallidus 
Induces an Increase In [i-1]lazabemlde 
binding (arrowhead), characteristic ol an 
astro;Jlial reaction (c) [~]PK11195 bind-
ing shO\l\'ing basal microglial levels in a 
contrd rat (d) A microglial reaction asso-
Qated with the AMPA micranjection in 
glcbus palli dus is detected as an increase 
in [~]PK11195 binding (arrO\l\'head) Bar, 
2mm 
J-I!1l) alter AMPA microinjection in globus pallidus [72] lit well 
wi!h !he second step !heay, whereas the small deposits 
(mean size 3 J-I!1l) obtained in hippocampus alter the same 
manipulation [78] may rellect the lack ol a catalysis agent Ior 
accretion, a an equilibrium belween lormation and solubi-
lization ol crystals, Furthermae, in rat striatum, blockade ol 
glial glutamate uptake [46] produces a sphericallesim with 
a central necrotic core surroonded by a penumbra zme 
similar to that caused by local ischemia, Three days alter the 
!reatment, an astroglial reaction and small Ca2+ deposits 
(mean diameter < 1 J-I!1l) were observed in the penumbra 
area, Eleven days later, these deposits had disappeared, 
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the pen umbra zone had recovered from injury and the 
necrotic area was partially repaired [46]. In this situation, 
compensatoty mechanisrns help normalize Ca2+ homeosta-
sis and avoid further neuronal death. The tissue recovers the 
ability to use extrusion mechanisms, and the re-solubiliza-
tion of Ca2+precipitates takes place. 
T ogether with Ca2+ deposits, the excitotoxic lesion in-
duces precipitation of uric acid and aluminosilicates, and 
the accumulation of sulphated mucosubstances [53]. The 
formation of these products may be related to the appear-
ance of tissue compensatory mechanisms. Uric acid, the 
end product of adenosine and guanosine catabolisrn, in-
creases after nucleic acid degradation, acts as antioxidant 
and protects mitochondria against glutamate-induced 
[Ca2+]¡ increase [104]. Moreover, adenosine inhibits neuro-
transrnitter release and a balance between excitatoty and 
inhibitory neurotransmission may prevent glutamate excito-
toxicity [9]. Consequently, the concentration of uric acid in-
creases during neurodegeneration [3] and, due to its limited 
solubility in physiological conditions, it easily precipitates as 
urate ctystals. Crystallization of aluminosilicates may also 
be related to a compensatory mechanism of [Ca2+]¡ in-
crease [74] becau se of the unique affinity of aluminium for 
silica acid. Precipitates of hydroxyaluminosilicates may 
therefore easily be formed to reduce aluminium toxicity. 
Similar cerebral formations have been described in several 
pathologies such as Alzheimer's or Fahr's diseases, where 
they would have a similar role. The functional meaning of 
mucosubstance accumulation remains unclear. In vitro min-
eralization models indicate that glycosaminoglycans and 
proteoglycans are effective competitive inhibitors of hydrox-
iapatite formation and growth [1]. This suggests that their 
accumulation in brain may reduce [Ca2+]¡ through Ca2+ se-
questration. However, if phosphorylated, they may partici-
pate directly in the nucleation of hydroxiapatite formation 
[1]. It should also be noted that, because of their high sul-
phur content, these mucosubstances may act as antioxi-
dants [53]. 
2.3.2. Human brain calcificafion and hypoxia-ischemia 
As hypoxic-ischemic injuty is a major cause of neurological 
sequelae through disturbances in Ca2+ homeostasis, and 
premature-neonates are more resistant to hypoxia-ischemia 
than term neonates, we also studied the relationship be-
tween differences in human brain vulnerability to hypoxia-is-
chernia during the perinatal period and brain calcification in 
basal ganglia, cerebral cortex, and hippocampus [77]. The 
number and size of the observed non-arteriosclerotic calcifi-
cations were area-specific and increased in term neonates. 
Basal ganglia presented the highest degree of calcification 
and hippocampus the lowest, mainly in the CA1 subfield. In 
all cases, neuronal damage was associated with astroglial 
reaction and Ca2+ precipitates, with microglial reaction ab-
sent in hippocampus. These data are consistent with those 
obtained after long-term excitotoxic lesions in rat brain and 
support the involvement of EAA receptors in hypoxia-is-
chemia damage, with a key role of mGluRI. They also sug-
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gest a marked similarity of the molecular and cellular mech-
anisrns underlying both processes. 
Comparison between lifespan and degree of calcification 
demonstrated that, in all cases, the highest calcified area 
was within two months after the hypoxia-ischemia, and that 
the semi-calcification time was very short (Iess than 10 days) 
(Figure 8). This last parameter, independent of subjective 
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Figure 8: Timing of the hypoxia-ischemia-induced calcification in 
basal ganglia, cerebral cortex and hippocampus of premature (n = 
3) and term (n = 5) human neonates. In the correlation study, the 
calcified area was calculated in a representative zone (1 mm2) of 
each cerebral area, t he lifespan corresponds to the time of injury in 
days. k, days to reach half of the maximal calcified area. 
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measurements, suggests that calcification depends on the 
degree ot brain differentiation and initial cerebral injuty, but 
not on the time-course ot the lesion. Moreover, the mec ha-
nisms leading to Ca2+ precipitation seem to be similar for all 
brain areas. If this is true, neu rons ot each eNS structure de-
generate through a common mechanism which is linked to 
disturbances in Ca2+ homeostasis. As each area ot the brain 
participates in specific physiological functions, the resultant 
pathology will depend on the specitic neuronal death ot the 
area affected. 
2.3.3. Aging, excitofoxicity and brain calcificafion 
Several studies suggest that aging increases neuronal vul-
nerability to toxic compounds, including drugs that impair 
energy metabolisrn and induce secondaty excitotoxic 
processes [14]. However, a decreased susceptibility of 
aged rats towards excitotoxins such as quinolinic or kainic 
acids has been reported [37]. Our data demonstrate that 
AMPA-induced Ca2+ deposits in rat hippocampus are age-
dependent since young rats (3 months oid) presented 
greater calcification area than middle-aged ones (15 months 
oid) [6]. In this study, glial reaction, y-aminobutiric acid 
(GABA)-uptake activity and immunostaining ot Ca2+ binding 
proteins showed the sam e respon se. Therefore the vulnera-
bility ot hippocampal neu rons to AMPA-induced neu rode-
generation decreases with age between 3 and 15 months. 
Similar results have been found in other brain areas such as 
the striatum and the nucleus basal is magnocellularis. This 
reduced vulnerability may be related to several factors. For 
example, age-associated variations in the relative abun-
dance of glutamate receptors and pre-synaptic alterations 
of glutamate release may explain, at least in part, an in-
creased resistance to excitotoxicity in the hippocampus 
[60,62]. 
This effect is compatible with the increased vulnerability 
to excitotoxicity obsetved in the eldest animals [14], since 
some of the factors responsible for the resistance to the in-
sult may follow a biphasic pattern, with a progressive in-
Table 2. 
Neurotransrnitter control 13 days 21 days 30 clays 
(n~15) (n~5) (n~5) (n~5) 
Glutamate 100 76±6 * 70±2 * 93 ± 10 
Taurine 100 56±3 * 69± 16 75 ± 11 
N oradrenaline 100 - - 63 ±5 * 
Octoparnine 100 34±3 * - -
Long-tenn effects of the basal forebrain excitotoxic lesion 
neurotransrnitter cortical extracellular levels. Columns are 
referred to post-Iesion tirne after ibotenic acid inj ection in 
basal forebrain. Values show percentage of the control and 
are expressed as rnean ± SEM. * P < 0.05 versus control 
based on the Mann-Whitney U test. 
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crease until maturity and a later decrease [19]. Many au-
thors have also described a biphasic variation of several pa-
rameters du ring aging, with an opposite tendency before 
and after middle-age [100]. We observed a biphasic varia-
tion ot monoamine oxidase B (MAO-B) during aging in most 
of the brain areas of humans: until the age of 50-60 years 
MAO-B levels remain unvaried and after start to increase 
[86]. This observation may be due to the presence ot MAO-B 
rich reactive astrocytes in response to neuronal degenera-
tion. In patients with Alzheimer's disease a similar increase 
has been tound in plaque-associated astrocytes [88]. As 
MAO-B activity is associated with ROS production, astro-
cytes may contribute to the age-associated decline of neu-
rological functions. The recent evidence that an increase in 
AMPA receptor correlates negatively with MAO-B in aged-
associated learning-impaired rats also suggests that a glio-
pathic reaction may be involved in neuronal dysfunction [2]. 
2.3.4. Neurodegenerafion, inhibitory neurofransmission and 
calcificafion 
To counteract excitotoxic processes after excessive gluta-
mate release, homeostatic changes have been reported in 
different areas of the brain. These changes include the re-
lease of inhibitoty neurotransrnitters, including adenosine 
and GABA. Thus, adenosine acts as a neuroprotector in hy-
poxia, ischemia and other situations [82]. Similarly, the si-
multaneous release of GABA with excitatory amino acids 
may counteract neuronal cell death during excitotoxicity and 
ischemia [85]. To clarity the role ot these neuromodulators 
during excitotoxicity, we studied the effects ot GABA and 
adenosine receptor antagonists on NMDA-induced excito-
toxicity in hippocampus. 
Blockade of adenosine A2a receptors induces an incre-
ment in NMDA-induced neuronal death and hippocampal 
atrophy. This enhanced reduction in the hippocampal area 
is also obsetved when a GABAA receptor antagonist is co-in-
jected with NMDA Surprisingly, treatment with these antag-
onists did not signiticantly modity the magnitude ot NMDA-
induced Ca2+ deposits [75]. Thus, in hippocampus, these 
inhibitoty neurotransrnitters may intetiere with the NMDA-in-
duced acute excitotoxic lesion by reducing only neuronal 
death. 
2.4. Transynaptic effects of excitotoxicity 
One of the consequences of excitotoxic-induced neuronal 
loss is the alteration of other neurotransmitter systems and 
neuromodulators. For example, as illustrated in T able 2, 
long-term ibotenic-induced lesion in the basal forebrain of 
rat leads to a loss of cholinergic afferences and to de-
creased extracellular noradrenaline, glutamate, and taurine 
[9,47]. This cortical reduction in glutamatergic transrnission 
presents a temporal pattern which, with the development of 
Ca2+ deposits and the decrease in the cholinergic and nora-
drenergic function [87], mimicks the neurochemical modifi-
cations described in Alzheimer's disease. Similarly one year 
after acute lesion, the cortical and hippocampal decrease in 
brain-derived neurotrophic factor, fibroblastic growth factor, 
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and glucocorticoid receptor, and the increase in e-fos ex-
pression in the septal area were still significant [10]. Thus, 
excitotoxic lesions in basal forebrain can modify long-term 
cortical adaptative responses, and may modulate the ex-
pression of glutamate receptor. Som e of these effects, such 
as the decrease in brain-derived neurotrophic factor and the 
increase in e-fos expression, also reflect the molecular alter-
ations present in Alzheimer's disease. 
Our experimental model may also help to explain this neu-
rological disorder. We showed a dramatic decrease in corti-
cal extracellular octopamine [4], a biogenic amine which, in 
rodents, decreases with age and is involved in the control of 
cognitive functions. The lack of data in human tissue opens 
a new line of study to investigate whether octopamine con-
stitutes a marker of age-associated neurodegeneration in 
humans. 
2.5. lintracellular calcium increase and energy failure 
The increase in [Ca2+]¡. and energetic loss can induce oth-
er interdependent mechanisms that are involved in neu-
ronal death, such as acidosis, ROS generation, and activa-
tion of proteases and endonucleases that trigger apoptotic 
death. 
2.5.1. Acidosis 
Excitotoxicity induces acidosis in cells and in the extracellu-
lar space [31]. There are several mechanisms by which pH 
decreases du ring neuronal injury. Mitochondrial damage 
forces the cell to a shift from aerobic to anaerobic metabo-
lism; as a result lactate is produced with the formation of two 
ATPs and the release of two protons. After trauma and is-
chemia, extracellular lactate increases dramatically and the 
pH decreases. To ensure neuronal viability during and even 
after human hypoxia, glial glucose is oxidized only to lactate, 
which is rapidly transported into neu rons for its complete ox-
idation [90]. Furthermore, H+ also appears during sorne 
chemical reactions such as phospholipid hydrolysis. In par-
allel, Ca2+ influx causes rapid cytoplasmic acidification 
[31,102] through a) the activity of membrane Na+fH+ ex-
changer to restore the Na+ gradient, and b) the Ca2+-depen-
dent displacement of protons bound to cytoplasmic anions 
[96]. 
Although the mechanisms by which acidosis produces 
neuronal damage remain unclear, som e hypotheses are 
proposed. H+ may reduce K+ conductance and thus faci li-
tate action potentials [50]. Moreover, reinforced by ener-
getic depletion, a decrease in pH inhibits the Na+fCa2+ ex-
change, thereby contributing to the breakdown of 
mernbrane potential and increasing, again, the [Ca2+]¡ (Fig-
ure 4). Acidosis may also inhibit neurotransmitter re-uptake, 
enhance free radical production or accelerate ONA damage 
[96]. However, a pH decrease helps prevent further neu-
ronal damage by NMOA receptor blockade and Ca'+ influx 
reduction into the cell [29,36]. 
2.5.2. Reactive oxygen species production 
ROS are molecules, ions or atoms with one unpaired el ec-
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tron in their most external engaged orbital, which makes 
them highly reactive. In normal conditions, low concentra-
tions of ROS are produced during cellular processes such 
as mitochondrial electronic transport and some enzymatic 
activities (e.g. MAOs, tyrosine hydroxilase, and xantine oxi-
dase). ROS may be involved in the modulation of som e 
physiological functions like the regulation of neuronal ex-
citability [103]. In neu rons, stimulation of NMOA receptor in-
duces the activation of the Ca2+-dependent phospholipase 
A2 with the subsequent production of arachidonic acid (Fig-
ure 2), which controls a phospholipidic metabolic pathway 
that is involved in the production of ROS [20]. These species 
can be eliminated by two antioxidant mechanisms: a) three 
molecules, namely ascorbic acid, vitamin E and glutathion, 
participate in reducing cellular ROS; and b) three enzymes 
degrade ROS activity in the brain, superoxide dismutase, 
quinone reductase and, the most abundant, astroglial glu-
tathion peroxidase. 
Ouring hypoxic injuty, the reduced flavin adenine din u-
cleotide and coenzyme Q auto-oxidize to produce ROS be-
cause of insufficient O2 availability [96]. As a consequence, 
cytochrorne e, which is normally confined to the mitochondr-
iai intermembrane space, is released into the cytosol [41], 
decreasing the cellular respiratoty capacity even further. 
Moreover, over-stimulation of NMOA receptors increases 
eicosanoid metabolism, which contributes to the uncon-
trolled increase in neuronal ROS [96]. 
Studies of ischemia and repetiusion have shown that high 
[Ca2+]¡ can activate a Ca2+-dependent protease which cat-
alyzes the xantine dehydrogenase conversion to xantine ox-
idase. Ischemia also induces ATP degradation to hypoxan-
tine, a substrate of xantine oxidase; O2 provided during 
repetiusion is the other substrate of the reaction. Conse-
quently, xantine oxidase is strongly activated and produces 
large amounts of uric acid and ROS. Free radicals interact 
with phospholipids, proteins, nucleic acids, glycosamino-
glycans (Figure 4) and, specially with amina acids that con-
tains sulfide and unsaturated fatty acids [20]. 
2.5.3. Protease activation, apoptosis and necrosis 
Proteases of the caspase and calpaine families have been 
implicated in neurodegeneration, as their activation can be 
triggered by Ca2+ influx and oxidative stress (Figures 4 and 
9). Ca2+ overload also activates endonucleases, a series of 
Ca'+ -dependent enzymes that degrade ONA and that may 
be involved in two morphologically distinct forms of neuronal 
degeneration: necrosis and apoptosis [96]. Necrosis is a 
chaotic process that involves rapid energy loss, acute 
swelling, and vacuolation of the cell body and neurites with 
subsequent Iysis of the cell which sp ilis the cells contents 
into the extracellularfluid. Apoptosis involves protein synthe-
sis, compaction of the cell body, nuclear fragmentation, and 
formation of cell surface blebs that may prevent exposure of 
surrounding cells to the content of the dying cell [55]. 
The dysregulation of neuronal Ca2+ homeostasis during 
acute ischemic insults, epileptic seizures, and traumatic 
brain injury may result in excessive stimulation of calpains 
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(See Section 1.4) [83]. Concerning caspases, there are at 
least two major pathways by which the initiator pro-caspas-
es are activated in response to death-inducing stimuli and 
subsequently cleave the effector enzymes [16] (Figure 9). 
Calpain is activated in most torms ot necrosis and in some 
torms ot apoptosis, while caspase 3 is only activated in neu-
ronal apoptosis [101]. Calpains could become over-activat-
ed under extreme conditions that result in sustained eleva-
tion ot cytosolic Ca2+ levels, which is generally associated 
with necrosis. Caspases, like calpains, are cytosolic cys-
teine proteases, but do not require Ca2+ for activity [101], al-
though they are also responsive to increase intracellular 
concentration of this ion[16]. 
Calpains and caspases have a finite number of cellular 
proteins as substrates, including cytoskeletal proteins, en-
zymes involved in signal transduction, cell-cycle proteins, 
and nuclear-repairing proteins [101]. Interestingly, NMDA 
and AMPA receptors also appear to be substrates for cal-
pains and caspases. Collectively, these findings suggest 
key roles for caspases and calpains in modulating neuronal 
Ca2+ horneostasis and in preventing excitotoxic necrosis. 
[16]. Additional calpain and caspase substrates that may be 
involved in regulating plasticity have been identified in stud-
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ies of two proteins linked to Alzheimer's disease: ¡3-amyloid 
precursor protein and presenilin-1. In addition to these two 
molecules, several other proteins linked to neurodegenera-
tive disorders, such as amyotrophic lateral sclerosis and 
Parkinson's disease, are caspase substrates. 
Although it was initially accepted that excitotoxicity leads 
to necrotic death, a wide continuous spectrum of situations 
between apoptosis and necrosis has recently been de-
scribed [63]. The factors that determine the pattern of neu-
ronal death seem to be the intensity of the lesion, the [Ca2+]¡ 
and the cellular energy capacity [81]; the apoptotic death 
being associated with the less severe injuty. The cell then 
prevents the uncontrolled release of intracellular com-
pounds (e.g. glutamate) and the subsequent inflammatory 
response of tissue. As ATP levels decrease, the necrotic 
process starts presenting a hybrid pattern of both neuronal 
deaths [81]. 
2.6. Our hypothesis on brain calcification 
The massive astroglial production of lactate to help compen-
sate neuronal energy depletion caused by excitotoxicity is a 
key factor in brain calcification. pH reduction associated 
with increased lactate concentration facilitates the solubility 
Figure 9: Pathways for protease activation. Calpains are activated when calcium increases in the cell. There are at least two major pathways by 
which the initiator pro-caspases (Ini casp) are activated in response to death-inducing stimuli, and subsequently cleave the effector caspases: 
one involves death receptors such as TNF and CD95, the other is a receptor independent process that consists of apoptotic signals such as 
calcium or ROS. Once activated, the death receptors recruit initiator caspases for their proteolytic activation. The apoptotic signals may act on 
the mitochondria to induce the release of cytochrome e, or on the nucleus to rel ease unknown apoptogenic factors (AF). (Adapted from Chan 
et al. 1999) 
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of Ca2+ and the formation of H2P04', HPO/ ' and P043, ions 
from inorganic phosphate [23] and phosphorylated pro-
teins. Because of the very high Ca'+ / H,PO; . HPOl . P043 -
affinity, apatite nucleation may occur with the subsequent 
growth of ctystalline formation along with neurodegenera-
tion. If this is the case, calcification of each lesioned area de-
pends not only on the density and subtype of glutamate re-
ceptors, phosphate availability and Ca2+ movements, but 
also on the differential capacity of glial cells to release lac-
tate during degeneration. 
Although the significance of cellular calcification is un-
known, a number of points suggest that it is part of the com-
pensatoty mechanisrns for excitotoxic neurodegeneration. 
For example, the obsetvation that mitochondria close to 
Ca2+ concretions appear normal at the electron microscopy 
level supports this hypothesis [53,78]. despite the fact that 
mitochondrial dysfunction constitutes a primaty event in 
NMDA-induced degeneration in cultured hippocampal neu-
rons [89]. This hypothesis is also consistent with Ihe finding 
that neurons undergoing prolonged stimulation of NMDA re-
ceptors can sutvive in the presence of [Ca2+]¡ chelators. 
Vety high levels of cytoplasmic Ca2+ are not necessarily 
neurotoxic, and an effective uptake of this element into mito-
chondria is required to trigger NMDA-receptor-stimulated 
neuronal death [93]. 
Olher results support this hypothesis. In rat globus pal-
lidus. the AMPA-dose-response study between 0.54 and 
21.6 mM has shown an increase in calcification which was 
not accompanied by an increase in astrogliosis [72]. In hip-
pocampus. 2.7 mM AMPA induced a calcified area larger 
than the injured area [5]. In this same structure, the selective 
adenosine-A2a-receptor antagon ist 8-(3-ch lorostyryl)-caf-
feine increased the NMDA-induced neuronal loss while cal-
cification was decreased [75]. Thus. all these data indicate 
that Ca2+ precipitation does not necessarily reflect neuronal 
death. They may also indicate that, as proposed for retinal 
excitotoxic damage [17], besi des Ca2+, other factors such 
as Na+ and CI' influx, K+ efflux and swelling induce excito-
toxic neuronal damage. 
Finally. several CNS disorders can be induced alter the 
same injuty becau se of differences in neuronal populations 
and abundance and distribution of glutamate receptor sub-
types. This variability is shown by the appearance of distinct 
neurodegenerative parameters and it determines the induc-
tion of a chronic processo Thus at the tissue level, the re-
sponse against the initial injuty is compensated or produces 
various lesions depending on the neuronal type involved, 
synaptic density, glial interactions, and vicinity of vascular-
ization. For each neuron and astrocyte type the crew of 
AMPA/kainate. NMDA and mGluR glutamate receptors. the 
Ca2+ binding protein content, protein phosphotylation levels, 
and all elements that participate in energetic needs and glu-
cose availability will be the factors involved in the appear-
ance of the lesion. 
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